155 related articles for article (PubMed ID: 26693066)
1. A VEGFR1 antagonistic peptide inhibits tumor growth and metastasis through VEGFR1-PI3K-AKT signaling pathway inhibition.
Zhou Z; Zhao C; Wang L; Cao X; Li J; Huang R; Lao Q; Yu H; Li Y; Du H; Qu L; Shou C
Am J Cancer Res; 2015; 5(10):3149-61. PubMed ID: 26693066
[TBL] [Abstract][Full Text] [Related]
2. Development of a novel albumin-based and maleimidopropionic acid-conjugated peptide with prolonged half-life and increased
Feng J; Zhao C; Wang L; Qu L; Zhu H; Yang Z; An G; Tian H; Shou C
Theranostics; 2018; 8(8):2094-2106. PubMed ID: 29721065
[TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor growth and metastasis by a VEGFR-1 antagonizing peptide identified from a phage display library.
An P; Lei H; Zhang J; Song S; He L; Jin G; Liu X; Wu J; Meng L; Liu M; Shou C
Int J Cancer; 2004 Aug; 111(2):165-73. PubMed ID: 15197767
[TBL] [Abstract][Full Text] [Related]
4. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of tumor growth by a peptide fusion protein binding to vascular endothelial growth factor receptor Flt-1].
Lei H; Shou C; Wu J; Liu X; He L; Liu M; Guo Q; Jiang B
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1342-5. PubMed ID: 12509940
[TBL] [Abstract][Full Text] [Related]
6. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
7. α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway.
Weng WT; Huang SC; Ma YL; Chan HH; Lin SW; Wu JC; Wu CY; Wen ZH; Wang EM; Wu CL; Tai MH
Biochim Biophys Acta; 2014 Jun; 1840(6):1850-60. PubMed ID: 24530634
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of Adp53 and F56 on growth and metastasis of transplantation of the breast tumor in mice].
Xiao SW; Yan B; Yang JX; Shou CC; Zhang SW
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 39(2):171-6. PubMed ID: 17440594
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of
Yu Q; Wang L; Ding J; Yang Z; Shou C; Zhao C; Zhu H
Bioorg Med Chem Lett; 2020 Jul; 30(14):127248. PubMed ID: 32527549
[TBL] [Abstract][Full Text] [Related]
10. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
11. Total Flavones of Abelmoschus manihot Exhibits Pro-Angiogenic Activity by Activating the VEGF-A/VEGFR2-PI3K/Akt Signaling Axis.
Zhu GS; Tang LY; Lv DL; Jiang M
Am J Chin Med; 2018; 46(3):567-583. PubMed ID: 29595071
[TBL] [Abstract][Full Text] [Related]
12.
Zhu H; Zhao C; Liu F; Wang L; Feng J; Shou C; Yang Z
ACS Med Chem Lett; 2017 Feb; 8(2):266-269. PubMed ID: 28197324
[No Abstract] [Full Text] [Related]
13. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer.
Zhu H; Zhao C; Liu F; Wang L; Feng J; Zhou Z; Qu L; Shou C; Yang Z
Am J Cancer Res; 2015; 5(11):3301-10. PubMed ID: 26807312
[TBL] [Abstract][Full Text] [Related]
15. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
[TBL] [Abstract][Full Text] [Related]
16. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
17. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
18. Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.
Sadremomtaz A; Kobarfard F; Mansouri K; Mirzanejad L; Asghari SM
J Recept Signal Transduct Res; 2018; 38(5-6):432-441. PubMed ID: 30929546
[TBL] [Abstract][Full Text] [Related]
19. A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis.
Farzaneh Behelgardi M; Zahri S; Mashayekhi F; Mansouri K; Asghari SM
Sci Rep; 2018 Dec; 8(1):17924. PubMed ID: 30560942
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-α regulates angiogenesis of BeWo cells via synergy of PlGF/VEGFR1 and VEGF-A/VEGFR2 axes.
Tanaka K; Watanabe M; Tanigaki S; Iwashita M; Kobayashi Y
Placenta; 2018 Dec; 74():20-27. PubMed ID: 30591201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]